679 reports of this reaction
3.3% of all CEFAZOLIN SODIUM reports
#1 most reported adverse reaction
HYPOTENSION is the #1 most commonly reported adverse reaction for CEFAZOLIN SODIUM, manufactured by Baxter Healthcare Corporation. There are 679 FDA adverse event reports linking CEFAZOLIN SODIUM to HYPOTENSION. This represents approximately 3.3% of all 20,322 adverse event reports for this drug.
Patients taking CEFAZOLIN SODIUM who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among CEFAZOLIN SODIUM users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for CEFAZOLIN SODIUM:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 679 FDA reports for CEFAZOLIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.3% of all adverse event reports for CEFAZOLIN SODIUM, making it one of the most commonly reported side effect.
If you experience hypotension while taking CEFAZOLIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.